Rong Rhonda Chen

Statistics

Publications

Citations

108

H-Index

Active since

2011

Affiliations

Boehringer Ingelheim (Japan)(Current)

Boehringer Ingelheim (United States)

Boehringer Ingelheim (France)

Rong Rhonda Chen is an author at Boehringer Ingelheim (Japan) specializing in cardiovascular pharmacodynamics, cardiovascular pharmacology, and pharmacodynamics.

Publications per year

2011–2012

Publications

The Clinically-tested S1P Receptor Agonists, FTY720 and BAF312, Demonstrate Subtype-Specific Bradycardia (S1P1) and Hypertension (S1P3) in Rat

Ryan M. Fryer, Akalushi Muthukumarana, Paul C. Harrison et al. · PLoS ONE · 2012 · 79 citations · Full text

Medicine, Pharmacology, Physiology +17

Mitigation of Off-Target Adrenergic Binding and Effects on Cardiovascular Function in the Discovery of Novel Ribosomal S6 Kinase 2 Inhibitors

Ryan M. Fryer, Akalushi Muthukumarana, Rong Rhonda Chen et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 18 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Strategic Integration of In Vivo Cardiovascular Models During Lead Optimization

Ryan M. Fryer, Paul C. Harrison, Akalushi Muthukumarana et al. · Journal of Cardiovascular Pharmacology · 2011 · 11 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–3 of 3